BioCube Inc
BioCube, Inc., a development stage company, focuses on the developing and marketing Li-ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. BioCube, Inc. is based in Bohemia, New York.
BioCube Inc (BICB) - Net Assets
Latest net assets as of October 2023: $3.43K USD
Based on the latest financial reports, BioCube Inc (BICB) has net assets worth $3.43K USD as of October 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.89K) and total liabilities ($7.46K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.43K |
| % of Total Assets | 31.51% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 70837.59 |
BioCube Inc - Net Assets Trend (2006–2016)
This chart illustrates how BioCube Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BioCube Inc (2006–2016)
The table below shows the annual net assets of BioCube Inc from 2006 to 2016.
| Year | Net Assets | Change |
|---|---|---|
| 2016-01-31 | $-2.32 Million | -93.39% |
| 2013-01-31 | $-1.20 Million | -20.56% |
| 2012-01-31 | $-994.12K | +3.75% |
| 2011-01-31 | $-1.03 Million | -10633.05% |
| 2010-01-31 | $-9.62K | +99.12% |
| 2009-01-31 | $-1.10 Million | -171.47% |
| 2008-01-31 | $1.53 Million | +141503.70% |
| 2006-01-31 | $1.08K | -- |
Equity Component Analysis
This analysis shows how different components contribute to BioCube Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 135948800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (January 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $96.74K | % |
| Other Comprehensive Income | $-96.74K | % |
| Other Components | $1.37 Million | % |
| Total Equity | $-950.00 | 100.00% |
BioCube Inc Competitors by Market Cap
The table below lists competitors of BioCube Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Stonebridge Resources Explorations Ltd
PINK:SRCX
|
$1.97 |
|
Flame Seal Products Inc
PINK:FLMP
|
$1.97 |
|
Curtis Mathes Corp
PINK:CMCZ
|
$1.97 |
|
AAP Inc
PINK:AAPJ
|
$1.97 |
|
Kuboo Inc
PINK:SGTB
|
$1.96 |
|
Atlantis Internet Group Corp
PINK:ATIG
|
$1.96 |
|
NOHO Inc
PINK:DRNK
|
$1.96 |
|
Rodedawg International Industries Inc
PINK:RWGI
|
$1.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BioCube Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 68,343 to -950, a change of -69,293 (-101.4%).
- Net loss of 39,350 reduced equity.
- Other comprehensive income decreased equity by 96,743.
- Other factors increased equity by 66,800.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-39.35K | -4142.11% |
| Other Comprehensive Income | $-96.74K | -10183.47% |
| Other Changes | $66.80K | +7031.58% |
| Total Change | $- | -101.39% |
Book Value vs Market Value Analysis
This analysis compares BioCube Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-01-31 | $0.00 | $0.00 | x |
| 2008-01-31 | $1.02 | $0.00 | x |
| 2009-01-31 | $-0.64 | $0.00 | x |
| 2011-01-31 | $-0.04 | $0.00 | x |
| 2012-01-31 | $-0.03 | $0.00 | x |
| 2013-01-31 | $-0.04 | $0.00 | x |
| 2020-01-31 | $0.00 | $0.00 | x |
| 2021-01-31 | $0.00 | $0.00 | x |
| 2022-01-31 | $0.00 | $0.00 | x |
| 2023-01-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BioCube Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-100.60%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -744.73% | -3.41% | 4.86x | 44.87x | $-8.17K |
| 2008 | -361.89% | -45.05% | 3.06x | 2.62x | $-5.70 Million |
| 2009 | 0.00% | -8.93% | 15.18x | 0.00x | $-3.87 Million |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-164.36K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-928.68K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $7.86K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-644.65K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-311.96K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-230.82K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-303.03K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-39.26K |
Industry Comparison
This section compares BioCube Inc's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BioCube Inc (BICB) | $3.43K | -744.73% | 2.17x | $1.96 |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |